Skip to main content
. Author manuscript; available in PMC: 2016 Apr 29.
Published in final edited form as: J Med Chem. 2013 Jun 20;56(13):5351–5381. doi: 10.1021/jm400177t

Table 9.

Optimization of Linker B

graphic file with name nihms497096t9.jpg

I10 µM / ICONTROL
(mean ± SEM, %)
EC50 (maximal potentiation)
(µM, %)a

R1 R2 R3 Z C=C GluN2C GluN2D GluN2C GluN2D
1 H OMe OMe O No 116 ± 2.9 123 ± 2.3 12 (145%) 11 (156%)
2 Cl OMe OMe O No 193 ± 7.3 179 ± 5.7 4.6 (233%) 5.0 (215%)
190 Br OMe OMe O No 183 ± 11 178 ± 6.6 0.9 (195%) 2.2 (188%)
154 F OMe OMe C No 92 ± 1.7 95 ± 2.3 -- --
155 H OMe OMe C Yes 122 ± 4.4 127± 5.1 35 (192%) 35 (199%)
156 Cl OMe OMe C Yes 169 ± 6.9 155 ± 6.4 1.1 (172%) 1.3 (157%)
157 Br OMe OMe C Yes 181 ± 17 169 ± 7.3 2.8 (188%) 2.8 (174%)
158 Cl H OMe C Yes 184 ± 13 187 ± 15 1.0 (190%) 1.0 (192%)
159 Br H OMe C Yes 172 ± 21 164 ± 11 1.5 (176%) 1.7 (185%)
160 H OMe OMe C No 102 ± 3.4 100 ± 2.9 -- --
161 Cl OMe OMe C No 114 ± 2.6 108 ± 2.0 -- --
162 Br OMe OMe C No 128 ± 5.2 134 ± 7.4 11 (129%) 15 (128%)
127 H OMe OMe S No 103 ± 4.3 94 ± 1.0 -- --
a

Fitted EC50 values are shown to two significant digits when potentiation at 10 µM test compound exceeds 115%; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 µM) and glycine (30 µM) responses. Data are from between 6–25 oocytes from between 2–5 frogs for each compound and receptor tested. Compounds 1, 2, 190 are also shown in preceding Tables, and are included here for comparison.